Welcome Introduction: A Landscape Update for Metastatic Breast Cancer—What Works? What Doesn’t? Strategies for Optimizing Survival: Can We Personalize Therapy for MBC? Joseph A. Sparano, MD
What Are the Best and Most Effective Chemotherapy Regimens for Metastatic Breast Cancer? To Sequence or Combine: That is the Question Stefan Glück, MD, Ph, FRCPC
Microtubules as a Target for Anticancer Drugs-Multi-Mechanistic Approaches to Mitigating Metastic Breast Disease Mary Ann Jordan, PhD
Survival Prolongation in MBC: The Role of Nontaxane Microtubule Dynamics inhibitors—Evidence and Implications of Recent Clinical Studies Javier Cortes, MD
Interactive Question and Answer Session Faculty Panel
